SCHEMBL1732832

SCHEMBL1732832

COc1cc(NC(=O)Cc2ccc(NC(=O)Nc3ccccc3)cc2)c(C(C)=O)cc1OC

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.62
ALDH1A1 P00352 3/20 0.62
HPGD P15428 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
HSD17B10 Q99714 2/20 0.62
RCE1 Q9Y256 1/20 0.62
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
BCHE P06276 2/20 0.54
ACHE P22303 2/20 0.54
LMNA P02545 1/20 0.53
EPHX2 P34913 1/20 0.52
POLB P06746 2/20 0.52
MAPT P10636 3/20 0.50
GAA P10253 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7481213 0.90 KDM4E (0.61) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL1732760 0.89 KDM4E (0.60) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL1732392 0.87 KMT2A (0.58) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL1733025 0.87 RAB9A (0.59) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL7482211 0.84 KDM4E (0.59) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL1733385 0.82 KDM4E (0.67) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL2038501 0.81 KDM4E (0.48) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL7481992 0.81 KDM4E (0.61) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL1733226 0.80 KDM4E (0.51) KDM4EALDH1A1HPGDNPSR1HSD17B10
SCHEMBL1732450 0.80 LMNA (0.51) KDM4EALDH1A1HPGDNPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9066912-B2 Drug-enhanced adhesion prevention ETHICON, INC. (US) 2015-06-30 US claimed
EP-1732486-B1 TRANILAST COMPOSITION FOR USE IN THE PREVENTION OF POSTOPERATIVE ADHESION ETHICON INC (US) 2014-05-07 EP claimed
EP-2035008-B1 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON INC (US) 2011-11-23 EP claimed
EP-1732486-A4 DRUG-ENHANCED ADHESION PREVENTION ETHICON INC (US) 2009-04-08 EP claimed
EP-2035008-A2 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS Ethicon, Incorporated (US) 2009-03-18 EP claimed
WO-2007146920-A2 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON, INC. (US) 2007-12-21 WO claimed
US-20070286892-A1 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON, INC. 2007-12-13 US claimed
JP-2007528391-A 2007-10-11 JP claimed
EP-1732486-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2006-12-20 EP claimed
WO-2005092264-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2005-10-06 WO claimed
US-20050106229-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US claimed
US-20050106230-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US claimed
US-9066912-B2 Drug-enhanced adhesion prevention ETHICON, INC. (US) 2015-06-30 US disclosed
EP-1732486-B1 TRANILAST COMPOSITION FOR USE IN THE PREVENTION OF POSTOPERATIVE ADHESION ETHICON INC (US) 2014-05-07 EP disclosed
EP-2035008-B1 COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS IN MAMMALS ETHICON INC (US) 2011-11-23 EP disclosed
EP-2335703-A1 Compositions and Methods for Preventing or Reducing Postoperative Ileus and Gastric Stasis in Mammals Ethicon, Incorporated (US) 2011-06-22 EP disclosed
EP-1732486-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2006-12-20 EP disclosed
WO-2005092264-A1 DRUG-ENHANCED ADHESION PREVENTION ETHICON, INC. (US) 2005-10-06 WO disclosed
US-20050106229-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US disclosed
US-20050106230-A1 Drug-enhanced adhesion prevention ETHICON, INC. 2005-05-19 US disclosed